Bitsch-Norhave Jens
Transaction: 04/16/2026
OTHER
Change
0
Price
Not reported
Filing
04/24/2026
Type
OTHER
Evaxion Biotech A/S
EVAX • Biotechnology
$3.12
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$26.02M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 231.6%Manageable debt level · 0.44Healthy liquidity · 5.85Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.12
Change0.00%
Shares Out8.34M
Market Cap$26.02M
Enterprise Value$7.58M
52W Range2.52 - 12.15
Beta0.26
P/E-2.67
P/S3.46
P/B1.97
EV/Sales1.01
EV/EBITDA-0.70
Price$3.12
Change0.00%
Shares Out8.34M
Market Cap$26.02M
Enterprise Value$7.58M
52W Range2.52 - 12.15
Beta0.26
P/E-2.67
P/S3.46
P/B1.97
EV/Sales1.01
EV/EBITDA-0.70
Earnings Yield-37.51%
FCF Yield0.00%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-122.66%
Profit Margin-102.38%
Debt/Eq0.44
Current Ratio5.85
Quick Ratio5.85
Target$9.00
Target Upside188.46%
Target Median$9.00
Target Range9.00 - 9.00
Volume12.58K
Avg Volume25.57K
EPS Surprise-0.43
Investment DNA
How strong this company looks for long-term investors
53
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
74/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
79/100
Why this score▼
Positive revenue growth · 231.6%Manageable debt level · 0.44Healthy liquidity · 5.85Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Price Target
2026-08-21
Low
$9.00
Mean
$9.00
Median
$9.00
High
$9.00
Insider Transactions
Recent executive and insider activity
Mattsson Andreas Holm
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/10/2026
Type
OTHER
Mattsson Andreas Holm
Transaction: 01/31/2025
OTHER
Change
+645,700
Price
$0.06
Filing
04/10/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bitsch-Norhave Jens | OTHER | 0 | Not reported | 04/16/2026 | 04/24/2026 |
| Mattsson Andreas Holm | OTHER | 0 | Not reported | 03/18/2026 | 04/10/2026 |
| Mattsson Andreas Holm | OTHER | +645,700 | $0.06 | 01/31/2025 | 04/10/2026 |
| Mattsson Andreas Holm | OTHER | +25,000 | $0.40 | 01/01/2024 | 04/10/2026 |
| Mattsson Andreas Holm | OTHER | +55,147 | $0.74 | 12/21/2023 | 04/10/2026 |
| Mattsson Andreas Holm | OTHER | +6,250 | $0.75 | 01/01/2023 | 04/10/2026 |
| Mattsson Andreas Holm | OTHER | +35,000 | $2.23 | 01/01/2022 | 04/10/2026 |
| Soegaard Marianne | OTHER | 0 | Not reported | 03/18/2026 | 04/02/2026 |
| Soegaard Marianne | OTHER | +184,500 | $0.06 | 01/31/2025 | 04/02/2026 |
| Soegaard Marianne | OTHER | +125,000 | $0.07 | 01/01/2024 | 04/02/2026 |
| Soegaard Marianne | OTHER | +183,824 | $0.74 | 12/21/2023 | 04/02/2026 |
| Soegaard Marianne | OTHER | +75,000 | $0.75 | 01/01/2023 | 04/02/2026 |
| Soegaard Marianne | OTHER | +10,000 | $2.23 | 01/01/2022 | 04/02/2026 |
| Soegaard Marianne | OTHER | +9,167 | $5.38 | 01/01/2021 | 04/02/2026 |
| Soegaard Marianne | OTHER | +25,812 | $0.10 | 01/01/2020 | 04/02/2026 |
| Wegner Lars Aage Staal | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Wegner Lars Aage Staal | OTHER | +46,100 | $0.06 | 01/31/2025 | 04/01/2026 |
| Wegner Lars Aage Staal | OTHER | +17,708 | $0.07 | 01/01/2024 | 04/01/2026 |
| Wegner Lars Aage Staal | OTHER | +36,765 | $0.74 | 12/21/2023 | 04/01/2026 |
| Wegner Lars Aage Staal | OTHER | +21,396 | $5.38 | 01/01/2021 | 04/01/2026 |